November 20, 2014
Slate By Jeremy Green Earlier this fall, a gathering of Washington politicians and wonks celebrated the birthday of a piece of paper: the Price Competition and Patent Extension Act of 1984, also known as the Hatch–Waxman Act. When the bill was signed into law 30 years ago, it streamlined the approval processfor … Continue to Article-->
November 17, 2014
The Subcommittee on Primary Health and Aging held a hearing on November 20, 2014 regarding skyrocketing generic drug prices. RxRights submitted 188 stories from our supporters for the hearing. A recording of the hearing and written testimony is available on the Subcommittee website. … Continue to Article-->
November 13, 2014
Have your generic drug prices gone up lately? If so, we’d like to hear about it. As Lee Graczyk mentions in an opinion piece that ran yesterday in The Hill’s Congress blog, generic drugs have long offered cash-strapped patients a viable alternative. But a recent analysis found that half of all generic drugs rose in … Continue to Article-->
November 12, 2014
This opinion piece was originally published on The Hill's Congress blog, November 12, 2014 Prescription drug prices have reached record levels, putting Americans at risk. U.S. citizens have long had to cope with excessive brand name drug prices and more and more can’t rely on generic drugs being affordable—as generic … Continue to Article-->
November 7, 2014
BioPharma Dive By Sy Mukherjee The Republican party strengthened its hold on the U.S. House of Representatives and took control of the U.S. Senate during Tuesday night's midterm elections. While some of the races have yet to be declared, the GOP will control at least 52 of the 100 Senate seats and 243 out of 435 … Continue to Article-->
Consumers should follow some basic best practices for choosing safe and legitimate online pharmacies from which to order prescription drugs.
New York Times
By Elisabeth Rosenthal
The first sign of trouble came when Dr. Barry Lindenberg, a cardiologist, received a three-page ...